Venlafaxine Hydrochloride Extended-Release Capsules USP recall
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Why was Venlafaxine Hydrochloride Extended-Release Capsules USP recalled?
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18
- Product
- Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
- Recalling firm
- Lucid Pharma LLC
- Quantity
- a) 44168 bottles; b) 24960 bottles
- Distribution
- Nationwide in the USA
- Recall date
- June 28, 2017
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)